Cochlear (Cochlear) Days Inventory

: 202.37 (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

Days Inventory is also known as Days Sales of Inventory (DSI). Cochlear's Average Total Inventories for the six months ended in Dec. 2023 was $212 Mil. Cochlear's Cost of Goods Sold for the six months ended in Dec. 2023 was $191 Mil. Hence, Cochlear's Days Inventory for the six months ended in Dec. 2023 was 202.37.

The historical rank and industry rank for Cochlear's Days Inventory or its related term are showing as below:

CHEOF' s Days Inventory Range Over the Past 10 Years
Min: 159.96 Med: 189.92 Max: 222.14
Current: 204.38

During the past 13 years, Cochlear's highest Days Inventory was 222.14. The lowest was 159.96. And the median was 189.92.

CHEOF's Days Inventory is ranked worse than
54.76% of 778 companies
in the Medical Devices & Instruments industry
Industry Median: 187.12 vs CHEOF: 204.38

Cochlear's Days Inventory declined from Dec. 2022 (228.07) to Dec. 2023 (202.37).

Inventory Turnover measures how fast the company turns over its inventory within a year. Cochlear's Inventory Turnover for the six months ended in Dec. 2023 was 0.90.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cochlear's Inventory-to-Revenue for the six months ended in Dec. 2023 was 0.29.

Cochlear Days Inventory Historical Data

The historical data trend for Cochlear's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cochlear Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Inventory

195.49

222.78

186.02

224.37

222.30

Cochlear Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Inventory																206.04	230.01	228.07	209.25	202.37

Competitive Comparison

For the Medical Devices subindustry, Cochlear's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cochlear Days Inventory Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Cochlear's Days Inventory distribution charts can be found below:

* The bar in red indicates where Cochlear's Days Inventory falls into.

Cochlear Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cochlear's Days Inventory for the fiscal year that ended in Jun. 2023 is calculated as

	Days Inventory (A: Jun. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Jun. 2022 )	+	Total Inventories (A: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2023 )	*	Days in Period
=	( (189.881	+	209.06)	/	2 )	/	327.517	*	365
=	199.4705					/	327.517	*	365
=	222.30

Cochlear's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (209.06	+	215.194)	/	2 )	/	191.298	*	365 / 2
=	212.127					/	191.298	*	365 / 2
=	202.37

Cochlear (OTCPK:CHEOF) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Cochlear's Inventory Turnover for the six months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	191.298	/	212.127
	=	0.90

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cochlear's Inventory to Revenue for the six months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	212.127	/	735.274
	=	0.29

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Cochlear Days Inventory Related Terms

Thank you for viewing the detailed overview of Cochlear's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Cochlear (Cochlear) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cochlear Ltd (OTCPK:CHEOF) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

CHEOY:USA OC5:Germany COH:Australia

Address

1 University Avenue, Macquarie University, Sydney, NSW, AUS, 2109

Website

https://www.cochlear.com

Cochlear is the leading cochlear implant device manufacturer with around 60% global market share. Developed markets contribute 80% of group revenue where cochlear implants are the standard of care for children with severe to profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2020, 49% of revenue came from the Americas, 35% from Europe, the Middle East, and Africa, and 16% from the Asia-Pacific segment.